Literature DB >> 1974862

Expression of growth factor and growth factor receptor RNA in rat pleural mesothelial cells in culture.

E Bermudez1, J Everitt, C Walker.   

Abstract

Mineral fiber-induced pleural mesothelioma in the rat is a suitable model for asbestos-induced mesothelioma in humans. A proposed mechanism for the genesis of mesotheliomas is the initiation of an autocrine pathway leading to unregulated growth of the mesothelium. To understand if changes in the expression of mRNA of critical growth factors and receptors occur in target mesothelial cells, it is first necessary to characterize the pattern of expression of these genes in normal mesothelial cells. Rat mesothelial cells were isolated from the parietal pleura and strains of these cells were propagated in vitro. The cells were diploid, had epithelial gross morphology and ultrastructure, and coexpressed keratins and vimentin. Northern blot analysis demonstrated that the cells expressed transforming growth factor beta 1 and fibroblast growth factor. Transcripts for transforming growth factor alpha, platelet-derived growth factor A-chain, and platelet-derived growth factor B-chain were not detected. Receptors for platelet-derived growth factor, epidermal growth factor, and insulin were detected. Although normal mesothelial cells express receptors for these growth factors, no production of their corresponding ligands by these cells could be detected, suggesting that autocrine stimulation of growth via the production of such factors may be specific to transformed mesothelial cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974862     DOI: 10.1016/0014-4827(90)90148-4

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

Review 1.  The mesothelial cell and its role in asbestos-induced pleural injury.

Authors:  M Kuwahara; E Kagan
Journal:  Int J Exp Pathol       Date:  1995-06       Impact factor: 1.925

2.  Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis.

Authors:  R K Coker; G J Laurent; S Shahzeidi; P A Lympany; R M du Bois; P K Jeffery; R J McAnulty
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

3.  Growth factor modulation of rat pleural mesothelial cell mitogenesis and collagen synthesis. Effects of epidermal growth factor and platelet-derived factor.

Authors:  M W Owens; S A Milligan
Journal:  Inflammation       Date:  1994-02       Impact factor: 4.092

4.  Growth stimulation of ovarian and extraovarian mesothelial cells by corpus luteum extract.

Authors:  S Setrakian; B Oliveros-Saunders; S V Nicosia
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-11       Impact factor: 2.416

5.  Cellular sources of transforming growth factor-beta isoforms in early and chronic radiation enteropathy.

Authors:  J Wang; H Zheng; C C Sung; K K Richter; M Hauer-Jensen
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

6.  Osteopontin mRNA expression by rat mesothelial cells exposed to multi-walled carbon nanotubes as a potential biomarker of chronic neoplastic transformation in vitro.

Authors:  Sreepradha Sridharan; Alexia Taylor-Just; James C Bonner
Journal:  Toxicol In Vitro       Date:  2021-02-27       Impact factor: 3.685

7.  Early mesothelial cell proliferation after asbestos exposure: in vivo and in vitro studies.

Authors:  I Y Adamson
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

8.  An enhanced and sensitive autocrine stimulation by transforming growth factor-alpha is acquired in the brain metastatic variant of a human non-small-cell lung cancer cell line.

Authors:  K Fang
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

9.  Enhanced paracellular barrier function of rat mesothelial cells partially protects against cancer cell penetration.

Authors:  H Tobioka; N Sawada; Y Zhong; M Mori
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.